Immunoblotting and real-time PCR analysis revealed that the enhanced expression of ACTN4 was observed in several basal-like breast cancer cell lines (MDA-MB-231, BT-549, and HCC1937) compared with the normal mammary cell line MCF-10A (Fig. 6a). This evidence concerns the gene ACTN4 and breast carcinoma.